World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000025538
Date of registration: 19/01/2015
Prospective Registration: No
Primary sponsor: Griffith University
Public title: Flushing in Peripheral intravenous catheters (FliP): A pilot, randomised controlled trial of high versus low frequencies and volumes in patients with a peripheral venous catheter.
Scientific title: To assess the effectiveness of high frequency flushing versus low flushing frequency and volume on device failure in patients with a peripheral venous catheter: The FliP pilot trial
Date of first enrolment: 28/04/2014
Target sample size: 160
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615000025538.aspx
Study type:  Interventional
Study design:  Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Factorial;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Dr Samantha Keogh   
Address:  Griffith University Nathan Campus Bldg N48 Rm 0.07 170 Kessels Road Brisbane Queensland 4111 Australia
Telephone: + 61 7 36464121
Email: s.keogh@griffith.edu.au
Affiliation: 
Name: Ms Julie Flynn   
Address:  Centre for Clinical Nursing Level 2, Building 34 RBWH Butterfield Street Herston Queensland 4029 Australia
Telephone: +61 7 36468293
Email: julie.flynn@griffith.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients greater than or equal to 16 years of age
PIVC to be inserted for clinical care
Informed consent to participate

Exclusion criteria: Planned removal of PIVC within next 24hrs
Previous enrolment in the current study


Age minimum: 16 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Peripheral cannula maintenance;
Peripheral cannula maintenance
Public Health - Health service research
Infection - Studies of infection and infectious agents
Intervention(s)
Participants will have their peripheral cannula (PIVC) flushed with one of the following, until the patient requires PIVC removal, by the nurse providing care for the patient:
1) Flushed every 6 hours with 3 ml Sodium Chloride 0.9%
2) Flushed every 24 hours with 10 ml Sodium Chloride 0.9%
3) Flushed every 24 hours with 3 ml Sodium Chloride 0.9%
AND
pre and post medication administration.
Primary Outcome(s)
Device failure (due to occlusion and/or infiltration).

PIVC occlusions may be thrombotic or nonthrombotic and may be partial or total in nature. Infiltration is when the IV fluid or drug enters the surrounding tissues rather than vein. PIVC patency is assessed by clinical nurses each shift in line with normal practice and will be documented on a data collection chart generated specifically for the study.[While PIVC is insitu.]
Secondary Outcome(s)
Phlebitis[Phlebitis scores will be collected daily while PIVC is insitu and on removal of PIVC.

Phlebitis indicators will be measured as follows:

Pain from site: (no pain) 0…..1…..2…..3…..4…..5…..6…..7…..8…..9…..10 (acute pain)

Tenderness: (no tenderness) 0…..1…..2…..3…..4…..5…..6…..7…..8…..9…..10 (acute tenderness)

Erythema: should be measured from entry point with a ruler and scored:
None, <1cm, >1cm but <2.5cm, >2.5cm but <5cm, >5cm

Swelling: should be measured from entry point with a ruler and scored:
None , <1cm, >1cm but <2.5cm, >2.5cm but <5cm, >5cm

Palpable Cord or Vein Streak: Yes/No
Less than 7.5cm, greater than 7.5cm
]
Dislodgement[Data will be collected at the daily check when PIVC has been documented as dislodged]
Laboratory confirmed bloodstream infection.

Electronic pathology results will be check 48 hours after PIVC has been removed.[While PIVC insitu or within 48 hours of PIVC removal]
Mortality[Rate of mortality will be assessed on completion of the trial]
Cost

Cost will be calculated based on the days each PIVC was insitu (per 1000 catheter days)[Cost will be calculated at the completion of the trial]
Dwell time - will be calculated from the insertion date and removal date fields[Following removal of PIVC]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Griffith University
Royal Brisbane & Women's Hospital
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Royal Brisbane & Womens Hospital
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history